Silk Road Medical (NASDAQ:SILK) Given New $21.00 Price Target at JPMorgan Chase & Co. : vimarsana.com

Silk Road Medical (NASDAQ:SILK – Free Report) had its price target lifted by JPMorgan Chase & Co. from $19.00 to $21.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a neutral rating on the stock. Several other equities analysts also recently weighed in on SILK. Stifel Nicolaus raised […]

Related Keywords

United States , Kevinm Klemz , Piper Sandler , Stifel Nicolaus , Andrews Davis , Company Profile , Goldman Sachs Group Inc , Bellevue Group , Securities Exchange Commission , Jpmorgan Chase Co , Nasdaq , Armistice Capital , Silk Road Medical , Free Report , Street Capital , Road Medical , Get Free Report , Exchange Commission , Sachs Group , Rubric Capital Management , Neuroprotection System , Stent System , Peripheral Access Kit , Dilation Catheter , Silk Road Medical Daily , Nasdaq Silk , Silk , Medical , Boost Price Target ,